Amarin Corp PLC (AMRN)
0.8545
-0.03
(-2.90%)
USD |
NASDAQ |
May 10, 16:00
0.8545
0.00 (0.00%)
After-Hours: 20:00
Amarin Price to Book Value: 0.6431 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 0.6623 |
| May 08, 2024 | 0.6494 |
| May 07, 2024 | 0.7339 |
| May 06, 2024 | 0.7375 |
| May 03, 2024 | 0.6849 |
| May 02, 2024 | 0.6909 |
| May 01, 2024 | 0.6317 |
| April 30, 2024 | 0.6931 |
| April 29, 2024 | 0.66 |
| April 26, 2024 | 0.6584 |
| April 25, 2024 | 0.6471 |
| April 24, 2024 | 0.661 |
| April 23, 2024 | 0.6646 |
| April 22, 2024 | 0.6513 |
| April 19, 2024 | 0.6465 |
| April 18, 2024 | 0.6559 |
| April 17, 2024 | 0.69 |
| April 16, 2024 | 0.674 |
| April 15, 2024 | 0.6911 |
| April 12, 2024 | 0.72 |
| April 11, 2024 | 0.7674 |
| April 10, 2024 | 0.7824 |
| April 09, 2024 | 0.7975 |
| April 08, 2024 | 0.805 |
| April 05, 2024 | 0.79 |
| Date | Value |
|---|---|
| April 04, 2024 | 0.7975 |
| April 03, 2024 | 0.7975 |
| April 02, 2024 | 0.7448 |
| April 01, 2024 | 0.6636 |
| March 31, 2024 | |
| March 28, 2024 | 0.6476 |
| March 27, 2024 | 0.6464 |
| March 26, 2024 | 0.6296 |
| March 25, 2024 | 0.6135 |
| March 22, 2024 | 0.625 |
| March 21, 2024 | 0.6263 |
| March 20, 2024 | 0.6521 |
| March 19, 2024 | 0.6306 |
| March 18, 2024 | 0.6085 |
| March 15, 2024 | 0.6244 |
| March 14, 2024 | 0.5975 |
| March 13, 2024 | 0.6274 |
| March 12, 2024 | 0.6285 |
| March 11, 2024 | 0.6512 |
| March 08, 2024 | 0.6711 |
| March 07, 2024 | 0.6739 |
| March 06, 2024 | 0.69 |
| March 05, 2024 | 0.6841 |
| March 04, 2024 | 0.6717 |
| March 01, 2024 | 0.7706 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4872
Minimum
Nov 02 2023
60.31
Maximum
Jul 05 2019
6.581
Average
2.501
Median
Nov 12 2021
Price to Book Value Benchmarks
| Trinity Biotech PLC | -- |
| DBV Technologies SA | 0.7930 |
| Adaptimmune Therapeutics PLC | 6.996 |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals Plc | 0.6842 |
Price to Book Value Related Metrics
| PS Ratio | 1.259 |
| Price to Free Cash Flow | 271.32 |
| Price | 0.8545 |
| Earnings Yield | -15.21% |
| Market Cap | 351.09M |